Optiver Holding’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$758 Buy
+1
New +$756 ﹤0.01% 1652
2026
Q1
– Sell
-183
Closed -$141K – 2673
2025
Q4
$141K Buy
+183
New +$124K ﹤0.01% 780
2025
Q2
– Sell
-186
Closed -$118K – 1616
2025
Q1
$118K Buy
+186
New +$128K ﹤0.01% 448
2024
Q2
– Sell
-214
Closed -$206K – 983
2024
Q1
$206K Buy
+214
New +$203K ﹤0.01% 478
2023
Q1
– Sell
-3
Closed -$2K – 566
2022
Q4
$2K Buy
+3
New +$2.21K ﹤0.01% 432
2022
Q1
– Sell
-109
Closed -$66K – 813
2021
Q4
$66K Hold
109
– – ﹤0.01% 374
2021
Q3
$66K Buy
109
+84
+336% +$52.1K ﹤0.01% 297
2021
Q2
$14K Buy
+25
New +$12.7K ﹤0.01% 417

Other funds holding REGN

Optiver Holding's REGN Position: Q3 2026 in Review

Optiver Holding opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1 share worth $758. The stake represents ﹤0.01% of the portfolio and ranks #1652 among its holdings. This is a return to the name: Optiver Holding previously reported a position in REGN as recently as Q4 2025.

Optiver Holding first reported a position in REGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $206K in Q1 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Optiver Holding held 1 share of Regeneron Pharmaceuticals worth $758 as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Optiver Holding position in Q3 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q3 2026, its #1652 holding.
  • Optiver Holding first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
  • Optiver Holding's Regeneron Pharmaceuticals position peaked at $206K in Q1 2024.
  • 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.